LY01008
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY01008, covering 2018-07-10 to 2018-07-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung Cancer [Phase 3]